@intel.. Tak ada yang mustahil dalam saham. GETS GLOBAL BERHAD dari 4.5 sen pada 23 Mac 2020 boleh mencecah setinggi RM3.97. Lebih dekat lagi dengan Nexgram (ready to be vaccine counter) ialah saham HWGB (disebabkan covid-19 vaksin) dari harga terendah 6 sen mencapai harga tertinggi RM1.03. Betullah kedua-duanya saham spekulatif....
EXPLOSIVE WARRANT WC BREWINGGGGG.... signal Q BUY 50188 meaning SYNDICATE FROM RHB ( formerly OSK188 ) now nibbling / courting with Q NO ENDING " 188 "
EXPLOSIVE WARRANT WC BREWINGGGGG.... signal Q BUY 50188 meaning SYNDICATE FROM RHB ( formerly OSK188 ) now nibbling / courting with Q NO ENDING " 188 "
>> MORE COMINGGGGGG....IMMEDIATE TP 4.5 SEN when MOM NEXGRAM 6 SEN
Abd Rahim Osman Pi klinik ambik ubat OKU_2020 Hang buat apa... Dok tgk saham ke ++++++++++ My friend Sdr Raheem....biar betol..ambil ubat sokmo ? Aku OK...boleh Pitih $ ...aku trade full time Trade Nexgram tak boleh buat style Bluechip sebab NG is an undisputed Cap Ayam Baru leh Pitih Sokmo $...
# Raheem...sat giii in No Time OKU Celup@Fake maii , dia Naik Angin & will THROWWWW Cold Water / Potong Stimm....
OK Raheem mimpi No 4 D ..esok Balonn..baru leh Kaya..We never know $
Nexgram, THE NEW GEM IN HEALTHCARE BUSINESSES AND VACCINE PRODUCER AND VACCINE DISRIBUTOR TO BE... UP.. UP... NEXGRAM ..................... Covid-19 VACCINE to manufacture and distribute (JV with Rafarma) and, Covid-19 Test Kits (agreement with MKN/MOH and MTC) Covid-19 Test (via subsidiary in Indonesia) Tracvirus with tracking vaccination is ready (contract with MOH) Tracvirus SafeTravelPass (contract with MOH) Medical gloves and PPE (gown) (contract with MAPU in Indonesia) NexgramBottleVaccine (via subsidiary operation
VACCINESLAB and RAFARMA desire to jointly develop and conduct initial clinical trial and expanded clinical trial (“Clinical Trial”) and invest in LARGESCALE COVID-19 VACCINE FACILITY IN INDONESIA (“Vaccine Plant”) exclusively for the above and other various vaccines as well as other immunological promising drug, use developed by RAFARMA, especially clinical trials in regional trial sites outside of USA and China with this MSJVA.
ni bukan nak just jadi distributor......BUT NAK BUKAK PLANT TU.......kikikikikih
Vaccine Lab + Rafarma Pharmaceuticals (US) + R. & D. Biocogency Laboratories Inc. (Cyprus) + subsidiary of Rafarma, PJSC Kraspharma (Russia) ———-> Russian or other source country Covid-19 vaccine ———> Indonesia and the ASEAN countries
Indonesia selected 6 types of vaccines including 3 types from china, 1 from US, 1 from britain, 1 local. china's sinovac has delivered 1.3m doses to Indonesia two days ago.
Only in Malaysia or it did happen in the rest of the world . Few cents company get into vaccine development and cheap to attract punter to frying up the stock
i tell u all it like u go play hit mouse game at theme park... it go up ozura will hit u down... in all related news, nexgram should at least fly to 0.10.. but.. it will not happen as ozura keep on dispose...
@JK22 Only in Malaysia or it did happen in the rest of the world . Few cents company get into vaccine development and cheap to attract punter to frying up the stock --------------------------------------------------------------- The answer:
JOINT VENTURE BETWEEN VACCINE LAB (s/o NEXGRAM) WITH RAFARMA (US company) (To open a vaccine facility in Indonesia to research, develop, conduct clinical trials and license for various in-demand vaccines including Covid-19)
R. & D. Biocogency Laboratories Inc (Cyprus) (parent company of RAFARMA) I RAFARMA (US) ------------------------------- JV Vaccines Lab (sub of NEXGRAM) I PJSC Kraspharma(sub of RAFARMA) (Russia)
THE JOINT VENTURE AGREEMENT TERMS:
----- RAFARMA plan includes the investment of approximately USD1,000,000,000 (US Dollar One Billion) for the joint venture.
----- VACCINESLAB will provide government joint venture, partnership, regulation, licenses, and incentives for the project
----- The production capacity of the plant is designed for 500-600 million doses, covering the needs of the entire territory of Indonesia and the ASEAN countries
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MZM2511
4,549 posts
Posted by MZM2511 > 2020-12-10 11:07 | Report Abuse
Oww. Their NOSH ist it?